Sign in

CIK 0001812364

  • Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. 4 Open-market sale Chief Financial Officer sold 864 shares at $21.56 ($18,628)
  2. 4 Open-market sale President, R&D sold 1,429 shares at $21.56 ($30,809)
  3. 4 Open-market sale Chief Legal Officer sold 864 shares at $21.56 ($18,628)
  4. 4 Grant or award Rahmer Peter acquired 97,630 shares (grant or award)
  5. 4 Open-market sale President and CEO sold 84,000 shares at an average $20.37 ($1,711,360)
  6. 4 Grant or award Chief Financial Officer acquired 101,115 shares (grant or award)
  7. 4 Grant or award Chief Legal Officer acquired 85,425 shares (grant or award)
  8. 4 Grant or award President, R&D acquired 160,390 shares (grant or award)
  9. 4 Open-market sale Chief Legal Officer sold 9,994 shares at $20.00 ($199,880)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale Chief Financial Officer sold 445 shares at $14.49 ($6,448)
  12. 4 Open-market sale President, R&D sold 980 shares at $14.49 ($14,200)
  13. 4 Open-market sale Chief Legal Officer sold 295 shares at $14.49 ($4,275)
  14. 4 Open-market sale President and CEO sold 42,000 shares at an average $20.06 ($842,520)
  15. 4 Open-market sale Chief Administrative Officer sold 448 shares at $21.54 ($9,650)
  16. 4 Open-market sale Chief Financial Officer sold 1,099 shares at $21.54 ($23,672)
  17. 4 Open-market sale President, R&D sold 9,817 shares at an average $22.53 ($221,138)
  18. 4 Open-market sale Chief Legal Officer sold 728 shares at $21.54 ($15,681)
  19. 4 Open-market sale President and CEO sold 42,000 shares at an average $21.04 ($883,680)
  20. 4 Open-market sale President, R&D sold 8,000 shares at $22.43 ($179,440)

Page 10 of 16 · 320 filings